Kiniksa Pharmaceuticals International Plc (KNSA)
45.78
-0.29
(-0.63%)
USD |
NASDAQ |
Mar 13, 16:00
46.00
+0.22
(+0.48%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Liabilities (Quarterly) : 196.03M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.346M |
| NovoCure Ltd. | 463.86M |
| LivaNova Plc | 1.406B |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Alterola Biotech, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.63M |
| Shareholders Equity (Quarterly) | 567.61M |
| Debt to Equity Ratio | 0.0167 |
| Current Ratio | 3.788 |
| Net Debt Paydown Yield | 0.01% |